Apricus Bio APRI
Apricus Bio APRI NexACT
Apricus Bio APRI NexACT
HOME ABOUT APRICUS PRODUCTS DEVELOPMENT PIPELINE INVESTOR RELATIONS ANALYST COVERAGE
Home  Investor Relations
 
Investor Relations

 
Profile

Apricus Bio is a San Diego-based revenue-generating pharmaceutical company, with commercial products and a broad pipeline across numerous therapeutic classes including multiple approved and marketed drugs.

Receive E-mail Alerts 

Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

   
 
Recent News

Date

Title

06/21/2013

Apricus Biosciences Presents Vitaros® Poster at the International Symposium on Prostate, Androgens and Men's Sexual Health

06/10/2013

Apricus Biosciences Receives European Approval for Vitaros® for the Treatment of Erectile Dysfunction

05/23/2013

Apricus Biosciences Prices $17.1 Million Public Offering of Common Stock and Warrants




Careers      Contact Us      Terms of Use Agreement      Privacy Policy      Safe Harbor       Subscribe      Sitemap

Apricus Bio APRI